Finance

Lists
Why is HESTERBIO up 2,19%?
Dive Deeper
HESTERBIO:NSE
Hester Biosciences Ltd
₹2 205,00
+2,19%
(+47,30) 1D
15 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for HESTERBIO...
Open
₹2 157,70
High
₹2 270,90
Low
₹2 156,90
Mkt. cap
18,76 mjd
Avg. vol.
6,40 k
Volume
5,37 k
Dividend
0,50%
Quarterly dividend
₹2,75
Ex-dividend date
14 Jul. 2026
P/E ratio
13,90
52-wk high
₹2 683,60
52-wk low
₹1 239,30
EPS
₹158,68
Shares outstanding
8,51 m
No. of employees
483
Open
₹2 157,70
High
₹2 270,90
Low
₹2 156,90
Mkt. cap
18,76 mjd
Avg. vol.
6,40 k
Volume
5,37 k
Dividend
0,50%
Quarterly dividend
₹2,75
Ex-dividend date
14 Jul. 2026
P/E ratio
13,90
52-wk high
₹2 683,60
52-wk low
₹1 239,30
EPS
₹158,68
Shares outstanding
8,51 m
No. of employees
483
News stories
From web sources and news partners
Profile
Hester Biosciences Limited is a publicly traded Indian animal and poultry vaccines manufacturing company, headquartered in Ahmedabad. Hester has plants situated in Gujarat and Nepal. Hester has a 30% share of the poultry vaccines market in India, making it the country's second largest poultry vaccine manufacturer. Hester is also the first commercial manufacturer of goat pox vaccine in India and manufactures PPR vaccines from both, Nigerian and Sungri strains. Wikipedia
About Hester Biosciences Ltd
CEO-
Employees483
Founded1983
Headquarters-
Sector-
Websitehester.in
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
709,69 m
774,15 m
1,02 mjd
772,44 m
Cost of goods sold
193,19 m
207,28 m
251,52 m
170,79 m
Cost of revenue
193,19 m
207,28 m
251,52 m
170,79 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
155,01 m
155,18 m
264,13 m
148,84 m
Operating expense
442,86 m
433,25 m
465,39 m
444,32 m
Total operating expenses
636,05 m
640,53 m
716,91 m
615,11 m
Operating income
73,64 m
133,62 m
299,41 m
157,33 m
Other non operating income
97,27 m
6,69 m
-133,21 m
16,43 m
EBT including unusual items
170,36 m
135,24 m
250,89 m
1,02 mjd
EBT excluding unusual items
170,36 m
135,24 m
203,96 m
163,33 m
Income tax expense
27,05 m
42,14 m
85,42 m
49,50 m
Effective tax rate
15,88%
31,16%
34,05%
4,87%
Other operating expenses
244,31 m
233,76 m
58,89 m
225,04 m
Net income
144,49 m
87,65 m
159,83 m
969,81 m
Net profit margin
20,36%
11,32%
15,73%
125,55%
Earnings per share
-
-
-
-
Interest and investment income
-
-
15,79 m
-
Interest expense
-22,07 m
-18,22 m
-15,77 m
-30,80 m
Net interest expenses
-22,07 m
-18,22 m
20,00 k
-30,80 m
Depreciation and amortization charges
43,54 m
44,31 m
59,14 m
70,44 m
EBITDA
116,32 m
174,66 m
330,34 m
188,26 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme